1173461

Cadila Pharmaceuticals Limited — FEI 3007684569

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ahmedabad (India)

Additional Details

Clinical BA/BE